ASCO 2021: Presentations about whole genome sequencing

At the congress of the American Society of Clinical Oncology (ASCO) on 4-8 June 2021 researchers Kris Samsom and Luuk Schipper of the Dutch Cancer Institute (NKI) have presented their findings on whole genome sequencing.

In the poster presentation

Whole Genome Sequencing (WGS) is feasible in routine clinical care

Kris Samsom of the Dutch Cancer Institute explains the results of their research in which they conclude that WGS is feasible in routine diagnostics.

In the poster presentation

Whole Genome Sequencing (WGS) improves sarcoma diagnosis and patient care

Luuk Schipper of the Dutch Cancer Institute explains how they came to the conclusion in their research that WGS can help improve the diagnosis and the treatment of patients with sarcomas.

More information

You read an article in the category Scientific publications. You may also be interested in Whole genome sequencing.
All news

Also read

Patients can benefit from whole genome sequencing for immunotherapy

Patients can benefit from whole genome sequencing for immunotherapy

01-10-2020

Immunotherapy is an effective treatment for many people with cancer. The number of abnormalities in the DNA of the tumor in …

In the media: Rarity – Personalised cancer treatment – fact not fiction

In the media: Rarity – Personalised cancer treatment – fact not fiction

28-02-2022

Imagine a world in which each person’s cancer is treated with a personalised, targeted medical treatment regimen. A world in …

Nature publication: High resolution DNA-image of metastatic tumor provides new treatment insights

Nature publication: High resolution DNA-image of metastatic tumor provides new treatment insights

19-10-2019

For the first time, Dutch researchers have created a detailed overview of the landscape of DNA-deviations in thousands of metastatic …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl